Drug Shortage Report for TEVA-FLUVASTATIN
Report ID | 139731 |
Drug Identification Number | 02299224 |
Brand name | TEVA-FLUVASTATIN |
Common or Proper name | FLUVASTATIN 20MG CAP |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | FLUVASTATIN |
Strength(s) | 20MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-05-19 |
Estimated end date | 2021-12-31 |
Actual end date | 2021-12-14 |
Shortage status | Resolved |
Updated date | 2021-12-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2021-12-17 | French | Compare |
v13 | 2021-12-17 | English | Compare |
v12 | 2021-11-25 | French | Compare |
v11 | 2021-11-25 | English | Compare |
v10 | 2021-10-21 | French | Compare |
v9 | 2021-10-21 | English | Compare |
v8 | 2021-09-23 | French | Compare |
v7 | 2021-09-23 | English | Compare |
v6 | 2021-08-13 | French | Compare |
v5 | 2021-08-13 | English | Compare |
v4 | 2021-07-29 | French | Compare |
v3 | 2021-07-29 | English | Compare |
v2 | 2021-05-20 | French | Compare |
v1 | 2021-05-20 | English | Compare |
Showing 1 to 14 of 14